Agilent Technologies, Inc. (NYSE:A - Get Free Report) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 3,150,000 shares, a growth of 9.8% from the November 30th total of 2,870,000 shares. Currently, 1.1% of the shares of the company are short sold. Based on an average daily trading volume, of 1,750,000 shares, the short-interest ratio is currently 1.8 days.
Agilent Technologies Stock Performance
A traded down $0.08 on Tuesday, reaching $134.34. The company had a trading volume of 719,606 shares, compared to its average volume of 1,713,347. The stock has a 50-day moving average price of $135.30 and a 200-day moving average price of $136.65. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. Agilent Technologies has a 1 year low of $124.16 and a 1 year high of $155.35. The stock has a market capitalization of $38.37 billion, a PE ratio of 30.39, a P/E/G ratio of 4.48 and a beta of 1.07.
Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.05. The company had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company's revenue was up .8% on a year-over-year basis. During the same period last year, the business posted $1.38 EPS. As a group, research analysts forecast that Agilent Technologies will post 5.56 EPS for the current fiscal year.
Agilent Technologies Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.248 per share. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, December 31st. Agilent Technologies's payout ratio is presently 22.40%.
Wall Street Analysts Forecast Growth
Several analysts have commented on the company. Sanford C. Bernstein dropped their price objective on Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a report on Tuesday, November 26th. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research report on Tuesday, November 26th. Bank of America lowered their price objective on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research report on Friday, December 13th. Evercore ISI lifted their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an "in-line" rating in a research report on Tuesday, October 1st. Finally, Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a report on Monday, December 9th. One research analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $143.62.
View Our Latest Report on Agilent Technologies
Institutional Trading of Agilent Technologies
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Livelsberger Financial Advisory purchased a new position in Agilent Technologies during the 3rd quarter valued at about $28,000. Ashton Thomas Securities LLC acquired a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $31,000. Fortitude Family Office LLC grew its holdings in Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock valued at $35,000 after buying an additional 95 shares during the last quarter. RPg Family Wealth Advisory LLC purchased a new position in Agilent Technologies during the third quarter worth $38,000. Finally, Ashton Thomas Private Wealth LLC purchased a new position in Agilent Technologies during the second quarter worth $39,000. Institutional investors and hedge funds own 87.42% of the company's stock.
About Agilent Technologies
(
Get Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.